SCYNEXIS Stock

SCYNEXIS Capital Expenditures

Capital Expenditures (CapEx) of SCYNEXIS (SCYX) as of Aug 4, 2026.

Capital Expenditures

0.00USD

Last updated:

Capital Expenditures (CapEx) of SCYNEXIS is 2026 0.00 USD. Capital Expenditures (CapEx) of SCYNEXIS was 2025 0.00 USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

Cash Flow — SCYNEXIS

All Key Metrics — SCYNEXIS